APTOSE BIOSCIENCES INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e70177e9-8967-407c-842c-68730c7d7c29/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-25.5M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-135012 |
| FY 2024 | $-25.4M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-046366 |
| FY 2023 | $-51.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-036537 |
| FY 2022 | $-41.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009560 |
| FY 2021 | $-65.4M | 2021-01-01 – 2021-12-31 | evidence 0001171843-22-002048 |
| FY 2020 | $-55.2M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-002006 |
| FY 2019 | $-26.3M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-001617 |
| FY 2018 | $-28.9M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001661 |
| FY 2017 | $-11.6M | 2017-01-01 – 2017-12-31 | evidence 0001171843-19-001661 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).